Helena Lutescia Luna Coelho
Overview
Explore the profile of Helena Lutescia Luna Coelho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vieira J, da Costa Lima E, Land M, Ventura M, Coelho H
Cad Saude Publica
. 2017 Jun;
33(5):e00169515.
PMID: 28614452
This study aimed to characterize the clinical trials with medicines enrolling Brazilian children and adolescents, registered in the databases of Clinical Trials and the Brazilian Clinical Trials Network (ReBEC) from...
2.
Costa D, Coelho H, Dos Santos D
Cad Saude Publica
. 2017 Mar;
33(2):e00126215.
PMID: 28300968
This cross-sectional prospective nested cohort study aimed to assess the prevalence of use of medication before and during pregnancy and associated factors in women in a municipality in the countryside...
3.
de Souza Jr A, Dos Santos D, Rey L, Medeiros M, Vieira M, Coelho H
BMC Pediatr
. 2016 Jan;
16:13.
PMID: 26795213
Background: Neonates admitted to neonatal intensive care units (NICU) are exposed to a wide variety of drugs, most without any data on safety and efficacy. Objective: To describe the drugs...
4.
Andrade M, Oliveira M, Nagao-Dias A, Coelho I, da Silva Candido D, Freitas E, et al.
Rev Soc Bras Med Trop
. 2014 Dec;
47(5):670-1.
PMID: 25467276
No abstract available.
5.
Andrade M, Oliveira M, Nagao-Dias A, Coelho I, da Silva Candido D, Freitas E, et al.
Rev Soc Bras Med Trop
. 2014 Jan;
46(6):776-8.
PMID: 24474023
Introduction: The role of trypanocidal therapy in the chronic phase of Chagas disease remains controversial. Methods: A total of 13 patients with chronic Chagas disease were treated with benznidazole (5mg/kg/day/60...
6.
Dos Santos D, Barreto M, Coelho H
Cad Saude Publica
. 2011 Oct;
27(10):2032-40.
PMID: 22031207
A cross-sectional study of children living in poor areas in the city of Salvador, Bahia State, Brazil, was carried out in 2006 to investigate the prevalence of use of prescribed...
7.
Santos D, Cruz A, Simoes S, Rodrigues L, Camargos P, Coelho H, et al.
Eur J Clin Pharmacol
. 2011 Jul;
68(1):73-82.
PMID: 21717145
Purpose: Despite the advances in asthma therapeutics, there are few data on the use and determinants of anti-asthmatic drugs in the general population of children. This study describes the use...
8.
de Pontes V, de Souza Junior A, Cruz F, Coelho H, Dias A, Coelho I, et al.
Rev Soc Bras Med Trop
. 2010 May;
43(2):182-7.
PMID: 20464150
Introduction: Chagas disease is caused by Trypanosoma cruzi and treated with benznidazole (BNZ). This drug has the troublesome features of presenting partial effectiveness and high toxicity ranging from hypersensitivity reactions...
9.
Opaleye E, Coelho H, Schuler-Faccini L, de Almeida P, Cavalcante Dos Santos E, Ribeiro A, et al.
Rev Bras Ginecol Obstet
. 2010 Mar;
32(1):19-35.
PMID: 20209258
Purpose: failed attempted abortions with the use of misoprostol (Cytotec(R)) without medical indication have been associated with the occurrence of congenital malformations. The objective of the present study was to...
10.
Santos D, Barreto M, Coelho H
Rev Saude Publica
. 2009 Oct;
43(5):768-78.
PMID: 19851631
Objective: To describe drug use profile in children living in poor areas and associated factors. Methods: Population-based, cross-sectional study, including 1,382 children aged between four and 11 years. These children...